Emergency Contraception in the US
Euromonitor International's Emergency Contraception in the US market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 48 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Table of contents
OTC HEALTHCARE IN THE US : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC industry proves recession resistant
Fusion of standard and herbal medicine emerges
Private label gains share
Retailers focus on consumer health
Industry growth is expected to remain dynamic
KEY TRENDS AND DEVELOPMENTS
America is becoming less healthy
Fusion of standard and natural medicine
Behind-the-counter category emerges
US economic slowdown promotes self-medication
Private label proves to be a tenacious competitor
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - USA
ADAMS RESPIRATORY THERAPEUTICS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Adams Respiratory Therapeutics Inc: Competitive Position 2008
BAYER CORP - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Bayer Corp: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 6 Bayer Corp: Competitive Position 2008
CHATTEM INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Chattem Inc: Key Facts
Summary 8 Chattem Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Chattem Inc: Competitive Position 2008
GENERAL NUTRITION CENTERS INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 General Nutrition Centers Inc: Key Facts
Summary 11 General Nutrition Centers Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 General Nutrition Centers Inc: Competitive Position 2008
GLAXOSMITHKLINE CONSUMER HEALTH - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 GlaxoSmithKline: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 GlaxoSmithKline: Competitive Position 2008
JOHNSON & JOHNSON INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Johnson & Johnson Inc: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008
Summary 17 Pfizer Consumer Healthcare Ltd: Competitive Position 2008
Summary 18 Johnson & Johnson Consumer Products Inc: Competitive Position 2008
Summary 19 Advanced Care Products: Competitive Position 2008
Summary 20 Neutrogena: Competitive Position 2008
MANNATECH INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Mannatech Inc: Key Facts
Summary 22 Mannatech Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 23 Mannatech Inc: Competitive Position 2008
MELALEUCA INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 24 Melaleuca Inc: Key Facts
Summary 25 Melaleuca Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 Melaleuca Inc: Competitive Position 2008
PROCTER & GAMBLE CO, THE - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Procter & Gamble: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Procter & Gamble: Competitive Position 2008
WYETH CONSUMER HEALTHCARE INC - OTC HEALTHCARE - USA
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Wyeth Consumer Healthcare: Key Facts
Summary 30 Wyeth Consumer Healthcare: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 31 Wyeth Consumer Healthcare: Competitive Position 2008
EMERGENCY CONTRACEPTION IN THE US
TRENDS
SECTOR DATA
Table 12 Sales of Emergency Contraception: Value 2006-2008
Table 13 Sales of Emergency Contraception: % Value Growth 2006-2008
Table 14 Emergency Contraception Company Shares by Value 2006-2008
Table 15 Emergency Contraception Brand Shares by Value 2006-2008
Table 16 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 17 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013